Form 4 Insulet Corporation For: 4 March
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Insulet Corporation (PODD)
Insulet Corporation stock price live, this page displays NASDAQ PODD stock exchange data. View the PODD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Insulet Corporation real time stock price chart below.
What Is the Insulet Corporation Stock Price Today?
The Insulet Corporation stock price today is 237.75.
What Is the Stock Symbol for Insulet Corporation?
The stock symbol for Insulet Corporation is ""PODD.""
What Stock Exchange Does Insulet Corporation Trade On?
Insulet Corporation is listed and trades on the NASDAQ stock exchange.
Is Insulet Corporation a Good Stock to Buy?
Determining whether Insulet Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PODD quote. (ISIN: US45784P1012) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
What Is the Insulet Corporation Stock Price Today?
The Insulet Corporation stock price today is 237.75.
What Is the Stock Symbol for Insulet Corporation?
The stock symbol for Insulet Corporation is ""PODD.""
What Stock Exchange Does Insulet Corporation Trade On?
Insulet Corporation is listed and trades on the NASDAQ stock exchange.
Is Insulet Corporation a Good Stock to Buy?
Determining whether Insulet Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PODD quote. (ISIN: US45784P1012) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
Currency in USD
237.75
+0.74(+0.31%)
Real-time Data·
Fair Value
An estimate of a Insulet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
234.66
239.39
52 wk Range
230.05
354.88
PODD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Insulet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
234.66239.39
52 wk Range
230.05354.88
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PODD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Insulet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
354.40
Upside
+49.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Insulet Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Insulet Corporation For: 24 February
- Investing.com
- Form 4 Insulet Corporation For: 4 March
- Investing.com
- Form 8K Insulet Corporation For: 24 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Insulet Corporation SWOT Analysis
Patch Pump Pionee | Insulet leads the insulin pump market with its innovative Omnipod 5 platform, boasting a $21.58 billion market cap and impressive 70.39% gross margins |
Financial Triumph | Explore Insulet's record-breaking Q1 2025 performance, with 30% worldwide growth and raised 2025 revenue guidance to 19-22%, signaling strong market momentum |
Market Expansion | Delve into Insulet's strategic moves in the Type 2 diabetes market and international expansion, unlocking vast growth potential in underpenetrated segments |
Analyst Optimism | Discover why analysts project bullish price targets ranging from $266 to $365, reflecting confidence in Insulet's technological advancements and market position |
Insulet Corporation Earnings Call Summary for Q4/2025
- Insulet's Q4 2025 revenue reached $784 million, exceeding forecasts with 29% growth in constant currency, while EPS of $1.44 slightly missed expectations.
- The company's stock surged 7.98% in pre-market trading to $266, reflecting investor optimism despite the minor EPS miss.
- For full-year 2025, Insulet achieved $2.7 billion in revenue (up 30.7%) with a gross margin of 71.6% and adjusted EPS of $4.97.
- Management projects 21-23% Omnipod revenue growth for 2026, with plans to expand operating margins by 100 basis points and increase adjusted EPS by over 25%.
- CEO Ashley McEvoy expressed confidence in the company's momentum, emphasizing 'Performance trumps everything' while highlighting upcoming product launches and market expansion.
Last Updated: 18/02/2026, 15:36
Read Full TranscriptCompare PODD to Peers and Sector
Metrics to compare | PODD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPODDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 67.5x | 2.6x | −0.5x | |
PEG Ratio | −1.69 | 0.00 | 0.00 | |
Price/Book | 11.0x | 8.1x | 2.6x | |
Price / LTM Sales | 6.2x | 4.3x | 3.2x | |
Upside (Analyst Target) | 51.9% | 28.1% | 51.2% | |
Fair Value Upside | Unlock | 12.8% | 7.3% | Unlock |
Analyst Ratings
24 Buy
1 Hold
1 Sell
Ratings:
26 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 354.40
(+49.06% Upside)
Earnings
Latest Release
Feb 18, 2026
EPS / Forecast
1.44 / 1.46
Revenue / Forecast
783.80M / 768.59M
People Also Watch
FAQ
What Is the Insulet (PODD) Stock Price Today?
The Insulet stock price today is 237.75 USD.
What Stock Exchange Does Insulet Trade On?
Insulet is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Insulet?
The stock symbol for Insulet is "PODD."
What Is the Insulet (PODD) Afterhours Price Today? (Afterhours variable test: 233.00) Current Date: Mar 09, 2026
After hours price: 233.00. After hours price change (units): -4.01. Price change percentage: -1.69%
What Is the Insulet Market Cap?
As of today, Insulet market cap is 16.69B USD.
What Is Insulet's Earnings Per Share (TTM)?
The Insulet EPS (TTM) is 3.48.
When Is the Next Insulet Earnings Date?
Insulet will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is PODD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Insulet Stock Split?
Insulet has split 0 times.
How Many Employees Does Insulet Have?
Insulet has 5400 employees.
What is the current trading status of Insulet (PODD)?
As of Mar 09, 2026, Insulet (PODD) is trading at a price of 237.75 USD, with a previous close of 237.01 USD. The stock has fluctuated within a day range of 234.66 USD to 239.39 USD, while its 52-week range spans from 230.05 USD to 354.88 USD.
What Is Insulet (PODD) Price Target According to Analysts?
The average 12-month price target for Insulet is 354.40 USD, with a high estimate of 435 USD and a low estimate of 286 USD. 24 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Buy. The stock has an +49.06% Upside potential.
What Is the PODD Premarket Price?
PODD's last pre-market stock price is 235.45 USD. The pre-market share volume is 20.00, and the stock has decreased by -1.56, or -0.66%.
What Is the PODD After Hours Price?
PODD's last after hours stock price is 233.00 USD, the stock has decreased by -4.01, or -1.69%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.